BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
33
Pharmacological evaluation and docking studies ofa,ß-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and proinflammatory cytokines.EBI
Universiti Kebangsaan Malaysia
9
Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.EBI
TBA
10
Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.EBI
University of Zagreb
7
Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.EBI
University of Alberta
5
New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.EBI
Iqog, Csic
12
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.EBI
China Pharmaceutical University
4
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.EBI
Aristotelian University of Thessaloniki
44
Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.EBI
The Medical University of Silesia
28
Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery.EBI
Abbottabad University of Science and Technology
77
Substituted pyridines as sodium channel blockersBDB
Purdue Pharma
6
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonistsBDB
Bristol Myers Squibb
3
Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.BDB
National Cancer Institute-Bethesda
17
Discovery of a novel class of selective human CB1 inverse agonists.BDB
Vernalis (R&D)
76
TPK AGONIST AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING SAMEBDB
Shanghai Raising Pharmaceutical Co.